None
Quote | Emmaus Life Sciences Incorporation (NYSE:EMMA)
Last: | $ |
---|---|
Change Percent: | -6.91% |
Open: | $1.90 |
Close: | $1.75 |
High: | $1.935 |
Low: | $1.51 |
Volume: | 43,926 |
Last Trade Date Time: | 02/12/2020 04:43:02 pm |
News | Emmaus Life Sciences Incorporation (NYSE:EMMA)
Emmaus Life Sciences Announces Outcome of FDA Inspection of Postmarketing Adverse Drug Experience Compliance Program PR Newswire TORRANCE, Calif. , July 12, 2024 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCPK: EMMA) , a commercial-stage biopharmaceuti...
2024-07-04 14:14:15 ET More on Emmaus Life Sciences Financial information for Emmaus Life Sciences Read the full article on Seeking Alpha For further details see: Emmaus Life Sciences GAAP EPS of -$0.07, revenue of $29.6M
Message Board Posts | Emmaus Life Sciences Incorporation (NYSE:EMMA)
Subject | By | Source | When |
---|---|---|---|
$EMMA about to go parabolic imo. Someone | aquaspin | investorshub | 01/20/2023 3:47:40 AM |
$EMMA .48 - I think the move higher | aquaspin | investorshub | 01/20/2023 12:40:10 AM |
$EMMA - CEO buying shares constantly. Insiders | aquaspin | investorshub | 11/16/2022 9:38:24 PM |
Stumbled across this potential gem. Things are looking | cheusmann | investorshub | 11/16/2022 3:02:08 PM |
Yup, if it fills the gaps Ill give | StockLogistics | investorshub | 10/31/2022 8:12:30 PM |
News, Short Squeeze, Breakout and More Instantly...
Emmaus Life Sciences Incorporation Company Name:
EMMA Stock Symbol:
NYSE Market:
Emmaus Life Sciences Incorporation Website:
Emmaus Life Sciences Announces Outcome of FDA Inspection of Postmarketing Adverse Drug Experience Compliance Program PR Newswire TORRANCE, Calif. , July 12, 2024 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCPK: EMMA) , a commercial-stage biopharmaceuti...
Emmaus Life Sciences Reports 2023 Financial Results PR Newswire TORRANCE, Calif. , July 3, 2024 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCPK: EMMA) , a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today r...
ADDvantage Technologies Group Inc. (AEYGQ) is expected to report for Q1 2024 ContraFect Corporation (CFRXQ) is expected to report for Q1 2024 American Clean Resources Group Inc (ACRG) is expected to report for Q1 2024 Atlantic Lithium Ltd Ord Fully Paid (ALLIF) is expected to report f...